-
-
-
-
-
-
-
Endo Int'l (ENDP) to Acquire DAVA Pharmaceuticals in $600M Deal
-
-
-
-
-
-
-
Notable Analyst Rating Changes 04/10: (AEO) (CYS) (GEO) Upgraded; (ARO) (THC) (NTAP) Downgraded
-
-
-
-
-
-
-
Endo Pharma (ENDP) September volatility at 30, January at 35; shares near 32-month high
-
-
56,417 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All